CONRAD
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, CONRAD sits in the top decile of US sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count).
CONRAD: 33 sponsored US clinical trials, none currently recruiting.
CONRAD sponsors 33 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 33 completed. 0 of these trials are in Phase 3-4 (later-stage) and 28 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Prevention, with 2 trials.
Top-decile sponsor footprint
CONRAD ranks in the top decile of sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
33 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
33 total, page 1 of 1
Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG
NCT03762772
Safety, PK, and PD Study of IVRs Releasing TFV and LNG
NCT03279120
PK and PD Study of Oral F/TAF for HIV Prevention
NCT02904369
Exploratory Pharmacodynamic Study of Tenofovir-Based Products
NCT02722343
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
NCT02569697
Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products
NCT02534779
A Safety Study Of The Caya® Diaphragm Used With ContraGel®
NCT02462954
Postcoital Testing Study of the SILCS Diaphragm Used With 3% N-9 Gel, ContraGel, or No Gel
NCT02309554
Comparison of Tenofovir Vaginal Gel and Film Formulations
NCT02280109
Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone
NCT02235662
The Role of Vitamin D in Female Reproductive Tract Immunity
NCT02186535
Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel
NCT01768962
In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
NCT01813162
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
NCT01989663
Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
NCT01687218
Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
NCT01810315
Biomarkers of Protocol Compliance and Product Adherence
NCT01804023
Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
NCT01694407
Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel
NCT01687205
Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
NCT01593124
Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use
NCT01421368
Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel
NCT01369303
Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue
NCT01347632
Rectal Safety and Acceptability Study of Tenofovir 1% Gel
NCT01232803
Microbicide Safety and Acceptability in Young Men
NCT01283360
Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom
NCT01178840
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
NCT00984971
Residence Time of Biomarkers of Semen Exposure
NCT00984555
Contraceptive Effectiveness and Safety of the SILCS Diaphragm
NCT00578877
Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
NCT00561496
Study of UC-781 Vaginal Microbicide
NCT00132444
Contraceptive Effectiveness Trial of Cellulose Sulfate Gel
NCT00255294
Postcoital Testing of the SILCS Diaphragm
NCT00561613
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 24 |
| Phase 2 | 4 |
Therapeutic Areas
How the CONRAD early-phase archive is shaped
33 indexed studies, none listed as recruiting (0% open); 33 completed (100%).
Phase mix: 0 late (III/IV) vs 28 early (I/II) (early-phase heavy).
Top condition: HIV Prevention (2 trials), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
CONRAD: archived-pipeline peers nationwide
Peers matched on 33 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
CONRAD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 33 archived trials
- Aclaris Therapeutics · 33 trials · 3% recruiting
- Antonios Likourezos · 33 trials · 12% recruiting
- Baylor University · 33 trials · 15% recruiting
- Becton, Dickinson and Company · 33 trials · 3% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this CONRAD page
33 registered trials is a research-attention snapshot, not an endorsement of CONRAD or any single study.
- None of CONRAD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- HIV Prevention is the condition CONRAD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Prevention trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
CONRAD pipeline card: 33 registered trials from official public datasets.Report a data error.